search
Back to results

CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke (COMET-AIS)

Primary Purpose

Ischemic Stroke, Acute, Thrombectomy, Anesthesia, General

Status
Recruiting
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
HYPERCAPNIA
NORMOCAPNIA
Sponsored by
University Hospital, Clermont-Ferrand
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ischemic Stroke, Acute focused on measuring mechanical thrombectomy, large vessel occlusion stroke, carbon dioxide tension, cerebral blood flow, general anesthesia, cerebral collateral circulation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

• Large vessel occlusion anterior circulation stroke (terminal carotid artery and/or middle cerebral artery M1-M2 segment) eligible to mechanical thrombectomy under general anesthesia

Exclusion Criteria :

  • Active smoker
  • Chronic respiratory failure with ambulatory oxygen supplementation
  • Obesity with BMI>40Kg/ m2
  • Intubation before the procedure
  • Heart failure with intolerance to decubitus
  • Severe renal failure
  • Suspected elevated intracranial pressure
  • Pregnant or breastfeeding women

Sites / Locations

  • CHURecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

HYPERCAPNIA

NORMOCAPNIA

Arm Description

Under general anesthesia with mechanical ventilation, PaCO2=50mmHg will be targeted

Under general anesthesia with mechanical ventilation, PaCO2=40mmHg will be targeted

Outcomes

Primary Outcome Measures

ASITN cerebral vascular collaterality score > 2
American Society of Interventional and Therapeutic Neuroradiology (ASITN) cerebral vascular collaterality score ranges from 0 (no collaterals visible to the ischemic site) to 4 (complete and rapid collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion). A score > 2 indicate at least collaterals with slow but complete angiographic blood flow of the ischemic bed by the late venous phase.

Secondary Outcome Measures

ASITN cerebral vascular collaterality score
American Society of Interventional and Therapeutic Neuroradiology (ASITN) variation during the procedure
Volume of cerebral infarction
Evaluated with Magnetic Resonance Imaging in milliliters
Progression of cerebral infarction
Evaluated with Magnetic Resonance Imaging or Computed Tomography in milliliters depending on type of radiological modality for patient selection
Neurological clinical outcome
Ordinal and dichotomized modified rankin scale (mRS) ranging from 0 (no disability) to 6 (death); good outcome will be defined as mRS 0-2.

Full Information

First Posted
July 9, 2021
Last Updated
December 21, 2022
Sponsor
University Hospital, Clermont-Ferrand
search

1. Study Identification

Unique Protocol Identification Number
NCT05051397
Brief Title
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
Acronym
COMET-AIS
Official Title
Evaluation of the Effect of Moderate and Controlled Hypercapnia on Ischemic Penumbra Vascular Collaterality During General Anesthesia for Anterior Circulation Acute Ischemic Stroke Mechanical Thrombectomy
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 20, 2022 (Actual)
Primary Completion Date
June 19, 2024 (Anticipated)
Study Completion Date
October 19, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Acute ischemic stroke due to large vessel occlusion is responsible of cerebral blood flow impairment with a progressive and extensive ischemic process. Cerebral collateral circulation may preserve an ischemic penumbra that could recover providing timely reperfusion of the occluded vessel. Mechanical thrombectomy is the standard of care for anterior circulation large vessel reperfusion. Strategy to promote cerebral blood flow in collateral circulation before reperfusion is scarce and rely mainly on blood pressure maintenance. Carbon dioxide is a potent cerebral vasodilator that could enhance collateral circulation blood flow and cerebral protection before reperfusion. General anesthesia with endotracheal mechanical ventilation could be used for thrombectomy and give the opportunity to modulate and control carbon dioxide tension in the blood. This study will test the effect of moderate hypercapnia on penumbral collateral circulation before reperfusion during mechanical thrombectomy for anterior circulation acute ischemic stroke under general anesthesia.
Detailed Description
Study will compare 2 groups of patients treated for anterior circulation large vessel occlusion stroke thrombectomy under general anesthesia. After anesthetic evaluation, patients will be randomized to receive moderate hypercapnia targeting an arterial CO2 tension (PaCO2) of 50mmHg or normocapnia targeting a PaCO2 of 40mmHg. The anesthetic protocol will use: Rapid sequence induction for orotracheal intubation with PROPOFOL 2mg/Kg and SUXAMETHONIUM 1mg/Kg SUFENTANIL 0,1 µg/Kg and CISATRACURIUM 0,1mg/Kg Maintenance with intravenous continuous infusion of PROPOFOL targeting a BISpectral index 40 to 60 Systolic blood pressure will have to be maintained +/- 10% of preoperative baseline value with limits between 120 and 185mmHg (with NOREPINEPHRINE as needed) Mechanical ventilation will use Tidal Volume of 7mL/Kg of ideal body weight, respiratory rate of 15/minute, End expiratory pressure of 5cmH2O. FiO2 will target SpO2 95-98%. Initial End Tidal CO2 (EtCO2) target will be 35mmHg. A first arterial blood gas analysis at groin puncture will evaluate CO2 alveolar-arterial gradient in order to obtain the expected PaCO2 in each group with respiratory rate modulation on the ventilator. ASITN baseline collaterality score will be evaluated at initial angiography with normocapnia in each group. A second evaluation of ASITN will be done just before deployment of intraarterial revascularisation device in hypercapnia or normocapnia depending on randomisation group. Targeted PaCO2 will have to be maintained using EtCO2 surrogate until the end of procedure. A second arterial blood gas analysis at the end of procedure will evaluate final PaCO2.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Stroke, Acute, Thrombectomy, Anesthesia, General, Cerebrovascular Circulation, Carbon Dioxide
Keywords
mechanical thrombectomy, large vessel occlusion stroke, carbon dioxide tension, cerebral blood flow, general anesthesia, cerebral collateral circulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
HYPERCAPNIA
Arm Type
Experimental
Arm Description
Under general anesthesia with mechanical ventilation, PaCO2=50mmHg will be targeted
Arm Title
NORMOCAPNIA
Arm Type
Active Comparator
Arm Description
Under general anesthesia with mechanical ventilation, PaCO2=40mmHg will be targeted
Intervention Type
Biological
Intervention Name(s)
HYPERCAPNIA
Intervention Description
Controlled moderate hypercapnia PaCO2 50mmHg under general anesthesia with mechanical ventilation
Intervention Type
Biological
Intervention Name(s)
NORMOCAPNIA
Intervention Description
Controlled normocapnia PaCO2 40mmHg under general anesthesia with mechanical ventilation
Primary Outcome Measure Information:
Title
ASITN cerebral vascular collaterality score > 2
Description
American Society of Interventional and Therapeutic Neuroradiology (ASITN) cerebral vascular collaterality score ranges from 0 (no collaterals visible to the ischemic site) to 4 (complete and rapid collateral blood flow to the vascular bed in the entire ischemic territory by retrograde perfusion). A score > 2 indicate at least collaterals with slow but complete angiographic blood flow of the ischemic bed by the late venous phase.
Time Frame
Before reperfusion of the occluded vessel
Secondary Outcome Measure Information:
Title
ASITN cerebral vascular collaterality score
Description
American Society of Interventional and Therapeutic Neuroradiology (ASITN) variation during the procedure
Time Frame
• At initial angiography in normocapnia and • Before reperfusion at randomized arterial CO2 tension level
Title
Volume of cerebral infarction
Description
Evaluated with Magnetic Resonance Imaging in milliliters
Time Frame
24 hours after stroke
Title
Progression of cerebral infarction
Description
Evaluated with Magnetic Resonance Imaging or Computed Tomography in milliliters depending on type of radiological modality for patient selection
Time Frame
24 hours after stroke
Title
Neurological clinical outcome
Description
Ordinal and dichotomized modified rankin scale (mRS) ranging from 0 (no disability) to 6 (death); good outcome will be defined as mRS 0-2.
Time Frame
3 months
Other Pre-specified Outcome Measures:
Title
Pial Vascular Collaterality within the symptomatic ischemic territory at admission
Description
Pial Vascular collaterality evaluated at admission with CT or MRI during patient selection for thrombectomy using the Pial Arterial Filling Score (from 0 indicated no collaterality to 5 indicating excellent collaterality)
Time Frame
At admission
Title
Arterial carbon dioxide tension
Description
Arterial carbon dioxide tension will be measured at 2 time points.
Time Frame
At groin puncture and at the end of procedure
Title
Cerebral infarction extension
Description
The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) is an imaging measure of the extent of ischemic stroke. Scores range from 0 to 10, with higher scores indicating a smaller infarct core.
Time Frame
Before thrombectomy and at day 1
Title
Reperfusion assessed by mTICI
Description
The modified Treatment In Cerebral Ischemia (mTICI) reperfusion scale ranging from 0 (no perfusion) to 3 (full perfusion with filling of all distal Branches). Good reperfusion will be defined as a score of 2B-3.
Time Frame
End of procedure
Title
Procedural delay
Description
Time frame from angiosuite admission to groin puncture to reperfusion if any
Time Frame
End of procedure
Title
Number of procedural anesthetic and radiological complications
Description
Procedural Safety outcomes
Time Frame
End of procedure
Title
Number of Death and neurological complications
Description
Safety outcomes
Time Frame
Day 7

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • Large vessel occlusion anterior circulation stroke (terminal carotid artery and/or middle cerebral artery M1-M2 segment) eligible to mechanical thrombectomy under general anesthesia Exclusion Criteria : Active smoker Chronic respiratory failure with ambulatory oxygen supplementation Obesity with BMI>40Kg/ m2 Intubation before the procedure Heart failure with intolerance to decubitus Severe renal failure Suspected elevated intracranial pressure Pregnant or breastfeeding women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lise Laclautre
Phone
+33 4 73 754963
Email
promo_interne_drci@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Russell Chabanne, MD MSc
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU
City
Clermont-Ferrand
ZIP/Postal Code
63000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Russell Chabanne, MD MSc
Email
rchabanne@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Russell Chabanne, MD MSc
First Name & Middle Initial & Last Name & Degree
Anna Ferrier, MD
First Name & Middle Initial & Last Name & Degree
Ricardo Moreno, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
31573636
Citation
Schonenberger S, Henden PL, Simonsen CZ, Uhlmann L, Klose C, Pfaff JAR, Yoo AJ, Sorensen LH, Ringleb PA, Wick W, Kieser M, Mohlenbruch MA, Rasmussen M, Rentzos A, Bosel J. Association of General Anesthesia vs Procedural Sedation With Functional Outcome Among Patients With Acute Ischemic Stroke Undergoing Thrombectomy: A Systematic Review and Meta-analysis. JAMA. 2019 Oct 1;322(13):1283-1293. doi: 10.1001/jama.2019.11455. Erratum In: JAMA. 2019 Dec 24;322(24):2445.
Results Reference
background
PubMed Identifier
30009645
Citation
Slupe AM, Kirsch JR. Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection. J Cereb Blood Flow Metab. 2018 Dec;38(12):2192-2208. doi: 10.1177/0271678X18789273. Epub 2018 Jul 16.
Results Reference
background
PubMed Identifier
29367334
Citation
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL; American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018 Mar;49(3):e46-e110. doi: 10.1161/STR.0000000000000158. Epub 2018 Jan 24. Erratum In: Stroke. 2018 Mar;49(3):e138. Stroke. 2018 Apr 18;:
Results Reference
background
PubMed Identifier
22495584
Citation
Willie CK, Macleod DB, Shaw AD, Smith KJ, Tzeng YC, Eves ND, Ikeda K, Graham J, Lewis NC, Day TA, Ainslie PN. Regional brain blood flow in man during acute changes in arterial blood gases. J Physiol. 2012 Jul 15;590(14):3261-75. doi: 10.1113/jphysiol.2012.228551. Epub 2012 Apr 10.
Results Reference
background
PubMed Identifier
6658900
Citation
Olsen TS, Larsen B, Herning M, Skriver EB, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke. 1983 May-Jun;14(3):332-41. doi: 10.1161/01.str.14.3.332.
Results Reference
background

Learn more about this trial

CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke

We'll reach out to this number within 24 hrs